Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for sedation during gastroscopy in patients with liver cirrhosis
ChiCTR2400091513Phase 4Not yet recruiting
- Sponsor
- Beijing Ditan Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Cirrhosis (2 arms), sponsored by Beijing Ditan Hospital. Primary endpoint: Incidence of hypotension. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on ChiCTR2400091513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091513.